These results were similar to those of other reports showing that DNMT inhibitors deplete DNMT1, 3a, and 3b proteins in human bladder, breast, and cervical cancer cells and hepatocellular carcinoma [30, 31, 38, 47]. The gene discussed is DNMT1; the disease is hepatocellular carcinoma.